How Long Does Rehab Take? Program Lengths Explained

How long rehab takes depends on your clinical needs, though most residential programs run 30, 60, or 90 days. Your medical team sets the timeline after a clinical assessment, not before it.

Detox is a separate stage with its own timeline. It usually runs days rather than weeks, and it happens before the rehabilitation phase begins.

Two people with the same substance can need very different lengths of stay. Withdrawal risk, co-occurring conditions, and prior treatment history all shift the answer.

The numbers you see advertised are program formats. What actually determines your length of stay is something more specific.

Key Takeaways

• NIDA sets a three month reference point. The National Institute on Drug Abuse reported that most people with addiction need at least three months in treatment to significantly reduce or stop substance use. That guidance dates to 2014 and was revised in 2018.
• The evidence on fixed duration is weaker than the industry implies. Pearson and colleagues meta-analyzed 232 treatment comparison studies in the Journal of Substance Abuse Treatment. Individualizing treatment held up. Remaining in treatment for a set adequate period did not.
• The American Society of Addiction Medicine criteria assess six dimensions of patient need, and those dimensions determine level of care and length of stay rather than a calendar.
• Withdrawal management typically resolves within days. The rehabilitation phase that follows addresses the psychological drivers of substance use over weeks or months.
• Treatment does not end when the program does. Continuing care extends recovery support after discharge, and DSM-5-TR classifies substance use disorders as chronic conditions requiring long term management.

Which Stage Does the Advertised Program Length Measure?

An advertised 30, 60, or 90 day program length measures the residential treatment stage only, not the withdrawal management that precedes it or the continuing care that follows it.

Why Each Stage Runs on a Separate Clock

Each stage of care in the drug and alcohol rehab process carries its own timeline, which is why total treatment time exceeds any single program length.

• Withdrawal management: Withdrawal management within residential treatment stabilizes the body as a substance clears the system. Physician-directed medication and continuous nursing oversight support this stage.
• Active rehabilitation: This is the stage the advertised program length refers to, and it runs weeks to months rather than days.
• Continuing care: Support after discharge extends for months, which places it outside the advertised program length entirely.

Why Length of Stay Is a Clinical Decision, Not a Package

Length of stay for substance use disorder reflects assessed medical necessity, which is why two people entering the same program can leave at different times.

• Assessment precedes the timeline: A clinical assessment documents substance use history, medical history, psychiatric status, and social circumstances before any duration is proposed.
• Plans get revised during treatment: Treatment teams reassess progress and modify the plan, which can extend or shorten the projected discharge date.
• Program formats are starting points: The 30, 60, and 90 day formats describe how facilities organize care, not how long a specific person clinically requires. The levels of addiction treatment map onto clinical need instead.
• Insurance authorization runs parallel: Utilization review evaluates continued medical necessity at intervals throughout the stay.

What Determines How Long Rehab Takes?

Substance type, withdrawal risk, co-occurring psychiatric conditions, and prior treatment history determine how long rehab takes for any individual.

Substance Type and Withdrawal Risk

The substance involved dictates the withdrawal management timeline, because different drug classes produce different physiological withdrawal syndromes.

• Alcohol withdrawal carries seizure risk: Abrupt cessation in physically dependent drinkers triggers autonomic hyperactivity. Severe cases of alcohol use disorder progress to delirium tremens, which requires intensive medical monitoring.
• Benzodiazepine cessation requires a medically directed taper: Abrupt discontinuation after prolonged use produces seizure risk, so the medical team individualizes the taper schedule rather than applying a fixed timeline.
• Opioid withdrawal severity is scored clinically: Clinicians grade severity with the Clinical Opiate Withdrawal Scale (COWS), which guides medication decisions such as buprenorphine initiation.
• Stimulant withdrawal is primarily psychological: Cocaine and methamphetamine cessation produces anhedonia, fatigue, and depressed mood rather than the autonomic instability seen with alcohol.

Co-Occurring Mental Health Conditions

Co-occurring psychiatric conditions extend length of stay because integrated treatment addresses both conditions simultaneously rather than sequentially.

• Untreated psychiatric symptoms drive relapse: Depression and anxiety generate the distress that substance use previously suppressed, which makes co-occurring disorders a primary target of residential care.
• Medication stabilization takes time: Psychiatric medications require weeks to reach therapeutic effect, and dose adjustments extend the observation period.
• Trauma histories complicate early recovery: Posttraumatic stress symptoms often surface once substances are removed, requiring trauma informed clinical support.
• Assessment continues after intake: Some psychiatric conditions only become diagnosable once acute intoxication and withdrawal have fully resolved.

Prior Treatment History and Relapse Patterns

Prior treatment episodes shape the recommended duration, because repeated relapse signals that shorter exposures did not produce durable change.

• Earlier short stays predict longer recommendations: Clinicians commonly recommend extended duration when previous 30 day episodes were followed by rapid return to use.
• Relapse is a treatment signal, not a failure: DSM-5-TR frames substance use disorder as a chronic condition, and recurrence prompts plan revision rather than discharge.
• Severity ratings inform duration: DSM-5-TR grades substance use disorder as mild, moderate, or severe based on the number of criteria met, and severity correlates with intensity of care needed.

Work, Family, and Practical Circumstances

Practical circumstances influence which program length a person can realistically complete, which affects clinical planning.

• Employment constraints shape planning: Confidential residential care for working professionals accounts for licensure concerns, leave arrangements, and privacy requirements.
• Caregiving responsibilities affect completion: Family obligations can shorten intended stays, so treatment teams build discharge planning around them from admission.
• Distance from home matters at discharge: Continuing care arrangements depend on what services exist in the person’s home community.

How Long Do 30, 60, and 90 Day Programs Last?

Residential programs are typically organized into 30, 60, and 90 day formats, with detox preceding them and continuing care following them.

Rehab Program Lengths at a Glance

The table below compares each stage of addiction treatment by typical duration, clinical purpose, and corresponding ASAM level of care.

Stage	Typical duration	Clinical purpose	ASAM level of care
Withdrawal management	Days, varying by substance	Medical stabilization as the substance clears	Delivered within the residential level of care
30 day residential	28 to 30 days	Stabilization, orientation to treatment, initial relapse prevention	Level 3 residential
60 day residential	Approximately 60 days	Deeper psychological work, medication stabilization, coping skill development	Level 3 residential
90 day residential	Approximately 90 days	Sustained behavior change, integrated treatment of co-occurring conditions	Level 3 residential
Extended care	Beyond 90 days	Support for repeated relapse or complex clinical need	Level 3 or Level 1 depending on intensity
Outpatient and continuing care	Months to years	Maintenance, relapse prevention, community reintegration	Level 1 outpatient

30 Day Programs

A 30 day residential program provides stabilization and an introduction to structured treatment for substance use disorder.

• What this length accomplishes: Thirty days establishes abstinence, completes withdrawal management, and introduces individual and group counseling.
• Who it typically suits: Clinicians consider this format for people with less severe substance use disorder, no significant withdrawal complications, and stable housing.
• Where it falls short: Thirty days provides limited time for psychiatric medication stabilization or sustained work on trauma and behavioral patterns.

60 Day Programs

A 60 day residential program extends the active treatment phase enough to address underlying psychological drivers of substance use.

• What the additional month adds: Sixty days allows deeper psychological evaluation, more sustained therapy, and observable response to psychiatric medication.
• Who it typically suits: This length fits people with moderate substance use disorder or co-occurring psychiatric conditions requiring medication adjustment.
• How discharge planning changes: The longer window allows continuing care arrangements to be built and confirmed before discharge rather than at the end.

90 Day Programs

A 90 day residential program aligns with the three month reference point NIDA identified for meaningful reduction in substance use.

• What sustained duration allows: Ninety days supports repeated practice of coping skills, which consolidates behavior change beyond initial abstinence.
• Who it typically suits: Clinicians consider this length for severe substance use disorder, repeated prior relapse, or complex co-occurring conditions.
• What the guidance actually says: The National Institute on Drug Abuse reported that most people with addiction need at least three months in treatment, and that the best outcomes occur with longer durations.

Extended Care Beyond 90 Days

Extended care continues structured support past the 90 day mark for people whose clinical picture warrants it.

• Who extended care serves: Repeated relapse, severe co-occurring psychiatric illness, or an unstable home environment can all justify duration beyond 90 days.
• What forms it takes: Extended residential care, step down to outpatient services, and sober living homes each extend the total support timeline at reduced clinical intensity.
• How the intensity shifts: Extended care generally reduces clinical intensity while maintaining structure, accountability, and access to counseling.

How ASAM Levels of Care Set Your Length of Stay

The ASAM Criteria assess six dimensions of patient need, and those assessments determine both the level of care and how long a person remains at that level.

What the ASAM Criteria Measure

The American Society of Addiction Medicine criteria evaluate a person across six dimensions rather than assigning care based on substance alone.

• Acute intoxication and withdrawal potential: This dimension assesses immediate physiological risk and determines whether medically supervised withdrawal management is required.
• Biomedical conditions and complications: Coexisting medical illness raises the level of monitoring a person needs during treatment.
• Emotional, behavioral, and cognitive conditions: Psychiatric symptoms and cognitive impairment influence both intensity and duration of care.
• Readiness to change: Motivational status shapes which interventions will engage the person and how long engagement takes.
• Relapse and continued use potential: Prior relapse history and current craving severity inform how long structured support is needed.
• Recovery environment: Housing stability, family support, and community resources determine what discharge is safe.

How Level of Care Changes Duration

Each ASAM level of care carries a different typical duration because each level delivers a different intensity of clinical service.

• Withdrawal management levels: These address acute physiological risk and typically resolve within days once the substance has cleared.
• Level 3 residential care: Residential treatment provides 24 hour structure and clinical staffing, and durations commonly span weeks to months. Level 3.5 designates clinically managed high-intensity residential care for adults.
• Level 1 outpatient care: Outpatient services deliver lower intensity support over longer periods, often measured in months.
• Movement between levels: Step down transitions a person to a less intensive level as clinical need decreases, which extends total treatment time while reducing daily intensity.

How Utilization Review Affects Length of Stay

Utilization review reassesses medical necessity at intervals during treatment, which is a second mechanism that shapes length of stay alongside clinical judgment.

• Authorization occurs in increments: Payers commonly authorize a set number of days and then reassess, rather than approving an entire stay at admission.
• Clinical documentation drives continuation: Treatment teams document ongoing symptoms and functional impairment to demonstrate that a higher level of care remains medically necessary.
• Financial planning is a separate question: What a longer stay costs and how coverage applies are addressed in detail on the page covering rehab cost.

What Does the Research Say About the 90 Day Threshold?

Federal guidance identifies three months as a reference point for treatment duration, while meta-analytic evidence has questioned whether a fixed duration threshold holds up.

What NIDA Reports on Treatment Duration

The National Institute on Drug Abuse addresses treatment duration directly in its principles of effective treatment.

• The published threshold: NIDA reported in its 2014 guide, revised in 2018, that research indicates most people with addiction need at least three months in treatment to significantly reduce or stop drug use.
• The stated qualifier: The same guidance notes that appropriate duration depends on the type and degree of each person’s problems and needs.
• Why premature exit matters: NIDA recommends that programs build strategies to engage and retain people in treatment, because early departure is common.
• Note the publication date: This guidance dates to 2014 with a 2018 revision, so it reflects the evidence base as assessed at that time.

Where the Evidence Is Contested

A large meta-analysis tested the NIDA principles empirically and did not support the duration principle, which is rarely mentioned in consumer content.

• What the study examined: Pearson and colleagues analyzed 232 treatment comparison studies as part of the Evidence based Principles of Treatment project, published in the Journal of Substance Abuse Treatment in 2012.
• What the analysis supported: Five principles held up, including matching treatment to the client’s needs, attending to multiple needs, behavioral counseling, and continual treatment plan reassessment.
• What it did not support: Remaining in treatment for an adequate period of time was one of two principles the pooled data did not support.
• How the authors interpreted this: They noted the principles may be stated too generally to apply across diverse programs, rather than concluding duration is irrelevant.
• What this means practically: The strongest supported principle is individualization, which is the argument for assessing each person rather than selling a fixed number of days.

How Does Detox Duration Affect Total Time in Treatment?

Detox duration is measured in days and driven by physiology, so it changes when rehabilitation begins rather than how long the rehabilitation phase itself runs.

How Withdrawal Duration Shifts the Overall Timeline

Withdrawal management duration varies by drug class, and that variation shifts when the rehabilitation phase can begin rather than changing its length.

• Alcohol and short acting opioids: Acute alcohol withdrawal and short acting opioid withdrawal typically resolve across several days, so the rehabilitation phase starts early in the stay.
• Long acting opioids and benzodiazepines: A medically directed taper extends the stabilization period, which pushes the full treatment timeline longer.
• Protracted withdrawal: Persistent sleep disturbance, mood symptoms, and craving after acute withdrawal resolves are a common reason clinicians extend length of stay.

Why Calendar Length Is Not a Fair Comparison

Comparing a residential program length against an outpatient program length is misleading, because the two formats deliver very different numbers of clinical contact hours per day.

• Contact hours differ sharply: A 30 day residential stay delivers continuous 24 hour care, while 30 days of outpatient rehab delivers a few scheduled hours per week.
• Judge duration by dose, not date: Length of stay is only meaningful alongside the intensity of care being delivered during it.

What Happens After Residential Treatment Ends?

Structured support continues after discharge through continuing care, recovery housing, and mutual help participation, because substance use disorder is a chronic condition.

Step Down and Continuing Care

Continuing care maintains clinical contact after residential discharge, which is the period of highest relapse vulnerability.

• What continuing care provides: Continuing care sustains counseling contact, monitors early warning signs, and adjusts support as circumstances change.
• Why the transition period matters: Returning to familiar environments reintroduces the cues and stressors that previously triggered substance use.
• How long it lasts: Continuing care duration is individualized and commonly extends for months after residential discharge.

Mutual Help Participation

Mutual help groups supply ongoing peer support at no cost, extending the support timeline indefinitely.

• What participation involves: Groups such as Alcoholics Anonymous and Narcotics Anonymous provide regular meetings and peer relationships built around sustained abstinence.
• How it fits with clinical care: Mutual help participation supplements professional treatment rather than replacing counseling or medication.
• Why duration is open ended: Participation continues as long as a person finds it useful, which is why total recovery support outlasts any treatment program.

Treatment Length at The Grove Estate

The Grove Estate determines length of stay through clinical assessment at its ASAM Level 3.5 residential facility on a 25 acre estate in Peru, Miami County, Indiana.

Licensing, Accreditation, and Level of Care

The Grove Estate holds a single designated level of care, which defines both what the facility delivers and how long clients stay.

• Designated level of care: The Grove Estate is licensed and designated to provide ASAM Level 3.5, Clinically Managed High-Intensity Residential care for adults, which is the sole level of care offered.
• State designation: The Indiana Family and Social Services Administration Division of Mental Health and Addiction lists The Grove Estate as an Active Provider at ASAM Residential Level 3.5, reference number 2145-010.
• National accreditation: The Joint Commission accredits the facility under its Behavioral Health Care and Human Services Accreditation Program, health care organization identification number 696218.
• Additional certification: LegitScript certification applies to the facility, with the certification badge displayed on the website.
• What this means for duration: A single designated level of care means length of stay decisions occur within residential treatment rather than by transferring between internal program tiers.

Withdrawal Management Within Residential Treatment

The Grove Estate delivers on site withdrawal management inside its licensed residential program rather than as a separate detox unit.

• How withdrawal is managed: Physician-directed medication and continuous monitoring support clients through supervised withdrawal from addictive substances.
• Who oversees care: Registered nurses provide 24 hour nursing oversight and monitor changing medical conditions throughout this stage.
• Staffing during this stage: The withdrawal management stage operates at a 4:1 client-to-staff ratio.
• How duration is set: The medical team determines this stage’s length based on the substance involved, withdrawal severity, and the client’s medical status.

Residential Rehab

Residential rehabilitation at The Grove Estate provides a 24 hour structured environment at ASAM Level 3.5 following withdrawal management.

• What the program includes: Residential rehab at the facility combines complete medical, nursing, and detoxification services within a single setting.
• How treatment is structured: Licensed clinicians lead clinical assessments and deliver both individual and group therapy sessions.
• How plans are individualized: Treatment planning follows a comprehensive physical examination and psychiatric evaluation rather than a preset format.
• Staffing during residential care: The residential program operates at a 12:1 client-to-staff ratio.
• How progress is reviewed: A psychiatric provider conducts weekly clinical rounds, which allows the plan and projected duration to be revised during the stay.

Dual Diagnosis Treatment

The Grove Estate treats co-occurring psychiatric conditions alongside substance use disorder rather than addressing them separately.

• How conditions are identified: A psychiatric provider conducts comprehensive psychiatric evaluations that identify co-occurring conditions requiring integrated treatment.
• How medication is handled: A medical provider performs physical examinations and medication reviews, which supports psychiatric medication management during the stay.
• How this affects duration: Integrated treatment of co-occurring conditions commonly extends the clinically appropriate length of stay.

Rehab for Working Professionals

The Grove Estate specializes in treating working professionals within a cohesive treatment setting.

• Why the population focus matters: Clients relate to others facing similar struggles, triggers, and occupational stressors, which supports engagement.
• What the setting provides: A 25 acre private estate in Peru, Indiana delivers a 24 hour supportive and structured environment.
• Where clients travel from: The estate sits roughly 20 miles from Kokomo and 25 miles from Marion, and serves the Indianapolis, Fort Wayne, and Lafayette areas.
• Who is eligible: The program accepts voluntary adult clients aged 18 and above.

Family Integration and Aftercare

The Grove Estate extends treatment beyond the individual through family programming and continuing care planning.

• What families receive: Family member education and counseling build stress management, communication, and leisure time skills.
• Why family involvement affects outcomes: An enhanced family support structure changes the recovery environment a person returns to at discharge.
• How care continues: Aftercare planning maintains consistency and continuity of treatment after the residential stay ends.

Frequently Asked Questions

What are the 5 stages of rehab?

Rehab is commonly described in five stages: assessment and intake, medically supervised withdrawal management, active treatment, discharge planning, and continuing care. Facilities label these stages differently, and the ASAM Criteria describe them as levels of care rather than fixed stages. Movement between stages depends on clinical progress rather than elapsed time.

What is the shortest rehab time?

Withdrawal management is the shortest stage and typically resolves within days, depending on the substance. Short residential programs generally run 28 to 30 days. Withdrawal management alone is not equivalent to rehabilitation, because it addresses physical dependence without treating the behavioral drivers of substance use disorder.

What is the average stay in a rehab facility?

Residential programs are most commonly organized in 30, 60, and 90 day formats, so the typical stay falls within that range. The National Institute on Drug Abuse reported in guidance published in 2014 and revised in 2018 that most people need at least three months in treatment. Individual length of stay depends on assessed clinical need.

Is a 30 day program long enough?

A 30 day program is sufficient for some people and insufficient for others, depending on withdrawal severity, co-occurring conditions, and prior treatment history. Thirty days provides limited time for psychiatric medication to reach therapeutic effect. Clinicians typically recommend longer duration when previous short stays were followed by rapid return to substance use.

Can you leave rehab early?

Voluntary treatment means a person can leave before completing a program, though leaving during withdrawal carries medical risk. Clinical teams discuss the risks of early discharge and document the discussion. Early departure is common enough that the National Institute on Drug Abuse recommends programs build specific strategies to retain people in treatment.

Does insurance cover a 90 day program?

Coverage for longer programs varies by plan, network status, and continued medical necessity documentation. Insurers commonly authorize care in increments and reassess rather than approving a full stay upfront. Verifying benefits before admission prevents an unplanned interruption partway through treatment.

What is the rehab phase of recovery?

The rehab phase is the active treatment stage that follows withdrawal management. It addresses the psychological and behavioral drivers of substance use through individual counseling, group counseling, and structured education. This phase differs from detox, which manages physical dependence, and from continuing care, which sustains support after discharge.

What are the 4 stages of recovery?

Recovery is often described in four stages: treatment initiation, early abstinence, maintaining abstinence, and advanced recovery. These descriptive stages are not diagnostic categories. DSM-5-TR classifies substance use disorder as a chronic condition and defines sustained remission in terms of criteria no longer being met over time.

References

1. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Association Publishing.
2. Mee-Lee, D., Shulman, G. D., Fishman, M. J., Gastfriend, D. R., & Miller, M. M. (Eds.). (2013). The ASAM criteria: Treatment criteria for addictive, substance-related, and co-occurring conditions (3rd ed.). American Society of Addiction Medicine.
3. National Institute on Drug Abuse. (2018). Principles of drug addiction treatment: A research-based guide (3rd ed.). National Institutes of Health. (Originally published January 2014; revised January 2018). Available at nida.nih.gov
4. Pearson, F. S., Prendergast, M. L., Podus, D., Vazan, P., Greenwell, L., & Hamilton, Z. (2012). Meta-analyses of seven of NIDA’s principles of drug addiction treatment. Journal of Substance Abuse Treatment, 43(1), 1–11.
5. Substance Abuse and Mental Health Services Administration. (2015). Detoxification and substance abuse treatment (Treatment Improvement Protocol Series, No. 45). Substance Abuse and Mental Health Services Administration.
6. Substance Abuse and Mental Health Services Administration. (2025). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health (HHS Publication No. PEP25-07-007). Available at samhsa.gov
7. Sullivan, J. T., Sykora, K., Schneiderman, J., Naranjo, C. A., & Sellers, E. M. (1989). Assessment of alcohol withdrawal: The revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar). British Journal of Addiction, 84(11), 1353–1357.
8. Wesson, D. R., & Ling, W. (2003). The Clinical Opiate Withdrawal Scale (COWS). Journal of Psychoactive Drugs, 35(2), 253–259.